IMMUNOGENICITY OF MULTIEPITOPE VACCINE CANDIDATE SPIKE AND NSP3 PROTEIN FUSION SARS-COV-2 IN BALB/C MICE
Since the outbreak of Coronavirus disease-2019 pandemic caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) in 2019, until now World Health Organization (WHO) has not declared the end of Covid-19 pandemic. Therefore, the urgency to develop a vaccine still remain an important is...
Saved in:
Main Author: | Meliana Shani, Annisa |
---|---|
Format: | Final Project |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/78406 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
IMMUNOGENICITY AND SAFETY OF A MUTIEPITOP PEPTIDE-BASED VACCINE CANDIDATE BASED ON SARS-COV-2 SPIKE AND NSP3 FUSION IN BALB/C MICE
by: Rofiqoh, Afifatur -
DEVELOPMENT OF MULTIEPITOPE PEPTIDE-BASED COVID-19 VACCINE CANDIDATE BASED ON SARS-COV-2 SPIKE AND NSP3 FUSION PROTEIN
by: Yamahoki, Nicholas -
IMMUNOGENICITY AND TOXICITY OF COVID-19 VACCINE CANDIDATE PROTEIN SUBUNIT PLATFORM RRBD SPIKE SARS-COV-2 IN BALB/C MICE
by: Aghniya Safitri, Intan -
OPTIMIZATION OF SPIKE AND NSP3 PROTEIN FUSION EXPRESSION FROM SARS-COV-2 USING E.COLI BL21(DE3) AT 37°C AS INITIAL DEVELOPMENT OF MULTIEPITOPE COVID-19 VACCINE CANDIDATES
by: Gunawan, Cynthia -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
by: Tuksin Jearanaiwitayakul, et al.
Published: (2022)